文献速递肝胆胰外科

动脉切除类型对胰腺癌动脉切除胰十二指肠切除术预后的影响

Prognostic Impact of type of Arterial Resection on Outcomes of Pancreatectomy with Arterial Resection for Pancreatic Adenocarcinoma.
PubMed 文献 · Ann Surg · 2025-06-09

该回顾性研究纳入1991年至2024年278例因胰腺腺癌行动脉切除联合胰腺切除术的患者,比较肝动脉、肠系膜上动脉、腹腔干等不同动脉切除类型的预后。结果显示动脉切除类型不影响总生存,术前CA19-9正常/正常化及肿瘤大小是独立预后因素。

要点

  • 动脉切除类型(肝动脉、肠系膜上动脉、腹腔干)不影响胰腺癌患者的总生存。
  • 术前CA19-9正常/正常化与更好的总生存相关。
  • 肿瘤大小(T3、T4)是总生存的独立不良预后因素。

核心结论

  • 动脉切除类型不影响接受动脉切除的胰腺腺癌患者的预后。
  • 对术前治疗的生物学和病理学反应是动脉切除术后更好的预后预测因素。

研究设计与样本

  • 回顾性评估1991年9月1日至2024年7月30日期间连续进行的动脉切除联合胰腺切除术。
  • 共纳入278例患者,行动脉切除类型包括肝动脉(n=74)、肠系膜上动脉(n=75)、腹腔干(n=117)和其他(n=12)。
  • 247例(88.8%)同时行静脉切除。

主要发现

  • 90天术后死亡率为5.39%,并发症发生率为47%。
  • 严重并发症的独立预后因素包括:围术期需要超过6单位红细胞(HR: 2.24; 95%CI: 1.41-4.39; P=0.002)和术后胰瘘(POPF)(HR: 3.64; 95%CI: 1.63-8.13; P=0.002)。
  • 中位总生存期自诊断起为26个月,自手术后为20个月(95%CI: 15.7-24.2个月),1年、3年和5年生存率分别为69%、28%和17%。
  • 各动脉切除类型的总生存相似:肝动脉(18.8个月,17.8%)、肠系膜上动脉(15.8个月,21.7%)、腹腔干(23.2个月,16%)。
  • 术前CA19-9正常/正常化(HR: 0.69; 95%CI: 0.48-0.98; P=0.04)和肿瘤大小(T3、T4)(HR: 3.26; 95%CI: 1.72-6.16; P=0.008)是总生存的预后因素。

临床怎么用

  • 动脉切除类型不应作为选择患者的唯一依据,术前治疗反应和肿瘤生物学行为更应关注。
  • 术前CA19-9正常/正常化和肿瘤分期(T3/T4)有助于预后分层。
  • 减少围术期输血和预防术后胰瘘可能降低严重并发症风险。

局限性

  • 回顾性研究设计。
  • 单中心经验,时间跨度大,治疗策略可能随时间变化。
  • 样本量有限,部分亚组病例数较少。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the prognostic implications of the type of arterial resection performed during pancreatectomy with arterial resection (PAR) for adenocarcinoma. SUMMARY OF BACKGROUND DATA: The advent of efficacious neoadjuvant treatment has led to renewed interest in PAR. Debate remains regarding the prognostic impact of the type of artery resected on short and long-term outcomes. METHODS: We retrospectively evaluated all consecutive PARs performed between September 1, 1991, and July 30, 2024. Multivariate logistic and Cox analyses were performed to identify prognostic factors for major morbidity and survival. RESULTS: A total of 278 patients consecutively underwent PAR during the study period. The type of artery resected included the hepatic arteries (HA) (n=74), superior mesenteric artery (SMA) (n=75), celiac trunk (CT) (n=117), and others (n=12). Simultaneously, venous resection was carried out on 247 patients (88.8%). Postoperative mortality and morbidity rates over 90 days stood at 5.39% and 47% respectively. From a multivariate regression analysis for severe morbidity, the following were identified as independent prognostic factors: need for more than six perioperative blood red units (HR: 2.24; CI 95%: 1.41-4.39; P=0.002), and POPF (HR: 3.64; CI 95%: 1.63-8.13; P=0.002). Median overall survival (OS) was 26 months from diagnosis and following surgery was 20 months (95% CI: 15.7-24.2 mo) with 1-, 3-, and 5-year survival rates of 69%, 28%, and 17% respectively. OS was similar among PAR: HA (18.8 mo, 17.8%), SMA (15.8 mo, 21.7%), CT (23.2 mo, 16%). Normal /normalized preoperative CA 19-9 (HR: 0.69; 95% CI: 0.48-0.98; P=0.04) and tumor size (T3, T4) (HR: 3.26; 95% CI: 1.72-6.16; P=0.008) were prognostic factors for OS. CONCLUSIONS: The type of arterial resection does not influence the prognosis for patients with pancreatic adenocarcinomas undergoing PAR. The biological and pathological response to preoperative treatment are better predictors of the prognosis after PAR for adenocarcinoma.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Bachellier P, Addeo P, Paul C, et al. Prognostic Impact of type of Arterial Resection on Outcomes of Pancreatectomy with Arterial Resection for Pancreatic Adenocarcinoma. Ann Surg. 2025. PMID: 40488404. doi:10.1097/SLA.0000000000006779

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。